质子泵抑制剂加速内皮细胞衰老。
Proton Pump Inhibitors Accelerate Endothelial Senescence.
作者信息
Yepuri Gautham, Sukhovershin Roman, Nazari-Shafti Timo Z, Petrascheck Michael, Ghebre Yohannes T, Cooke John P
机构信息
From the Department of Cardiovascular Sciences, Center for Cardiovascular Regeneration, Houston Methodist Research Institute, TX (G.Y., R.S., T.Z.N-.S., J.P.C.); Department of Chemical Physiology, Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA (M.P.); and Department of Radiation Oncology, Baylor College of Medicine, One Baylor Plaza, Houston, TX (Y.T.G.).
出版信息
Circ Res. 2016 Jun 10;118(12):e36-42. doi: 10.1161/CIRCRESAHA.116.308807. Epub 2016 May 10.
Abstract
RATIONALE
Proton pump inhibitors (PPIs) are popular drugs for gastroesophageal reflux, which are now available for long-term use without medical supervision. Recent reports suggest that PPI use is associated with cardiovascular, renal, and neurological morbidity.
OBJECTIVE
To study the long-term effect of PPIs on endothelial dysfunction and senescence and investigate the mechanism involved in PPI-induced vascular dysfunction.
METHODS AND RESULTS
Chronic exposure to PPIs impaired endothelial function and accelerated human endothelial senescence by reducing telomere length.
CONCLUSIONS
Our data may provide a unifying mechanism for the association of PPI use with increased risk of cardiovascular, renal, and neurological morbidity and mortality.
摘要
理论依据
质子泵抑制剂（PPIs）是治疗胃食管反流的常用药物，目前无需医疗监督即可长期使用。最近的报告表明，使用PPIs与心血管、肾脏和神经疾病有关。
目的
研究PPIs对内皮功能障碍和衰老的长期影响，并探讨PPIs诱导血管功能障碍的机制。
方法与结果
长期接触PPIs会损害内皮功能，并通过缩短端粒长度加速人内皮细胞衰老。
结论
我们的数据可能为使用PPIs与心血管、肾脏和神经疾病及死亡风险增加之间的关联提供一个统一的机制。
相似文献
1
Proton Pump Inhibitors Accelerate Endothelial Senescence.质子泵抑制剂加速内皮细胞衰老。
Circ Res. 2016 Jun 10;118(12):e36-42. doi: 10.1161/CIRCRESAHA.116.308807. Epub 2016 May 10.
2
Different transcriptional profiling between senescent and non-senescent human coronary artery endothelial cells (HCAECs) by Omeprazole and Lansoprazole treatment.奥美拉唑和兰索拉唑治疗对衰老和非衰老人类冠状动脉内皮细胞（HCAECs）的不同转录谱分析。
Biogerontology. 2017 Apr;18(2):217-236. doi: 10.1007/s10522-016-9675-3. Epub 2016 Dec 30.
3
Chronic use of proton pump inhibitors, adverse events and potential biological mechanisms: A translational analysis.质子泵抑制剂的长期使用、不良事件及潜在生物学机制：一项转化分析
Therapie. 2018 May-Jun;73(3):273-281. doi: 10.1016/j.therap.2017.08.003. Epub 2017 Oct 14.
4
Nissen fundoplication proton pump inhibitors for laryngopharyngeal reflux based on pH-monitoring and symptom-scale.基于 pH 监测和症状量表的尼森胃底折叠术质子泵抑制剂治疗喉咽反流
World J Gastroenterol. 2017 May 21;23(19):3546-3555. doi: 10.3748/wjg.v23.i19.3546.
5
The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux-A Prospective Longitudinal Interventional Study.质子泵抑制剂对胃食管反流婴儿粪便微生物组的影响：一项前瞻性纵向干预研究。
Front Cell Infect Microbiol. 2017 Oct 11;7:444. doi: 10.3389/fcimb.2017.00444. eCollection 2017.
6
Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.质子泵抑制剂在胃食管反流病中的作用：益友还是劲敌？
Curr Gastroenterol Rep. 2017 Sep;19(9):46. doi: 10.1007/s11894-017-0586-5.
7
Proton Pump Inhibitors: Review of Emerging Concerns.质子泵抑制剂：新出现问题的综述。
Mayo Clin Proc. 2018 Feb;93(2):240-246. doi: 10.1016/j.mayocp.2017.10.022.
8
Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.未选择的无症状胃食管反流病患者使用质子泵抑制剂后的食管酸暴露情况
J Clin Gastroenterol. 2008 Oct;42(9):969-73. doi: 10.1097/MCG.0b013e31814b8fc2.
9
Prolonged utilization of proton pump inhibitors in patients with ischemic and valvular heart disease is associated with surgical treatments, weight loss and aggravates anemia.缺血性和瓣膜性心脏病患者长期使用质子泵抑制剂与手术治疗、体重减轻有关，并会加重贫血。
Int J Cardiol. 2016 Sep 15;219:277-81. doi: 10.1016/j.ijcard.2016.06.058. Epub 2016 Jun 19.
10
Practical considerations in the management of proton-pump inhibitors.质子泵抑制剂管理中的实际考量
Rev Esp Enferm Dig. 2016 Mar;108(3):145-53. doi: 10.17235/reed.2015.3812/2015.
引用本文的文献
1
Association between proton pump inhibitor use and the risk of myocardial infarction: A cross-sectional study based on NHANES 2007 to 2018.质子泵抑制剂的使用与心肌梗死风险之间的关联：一项基于2007年至2018年美国国家健康和营养检查调查（NHANES）的横断面研究。
Medicine (Baltimore). 2025 Aug 29;104(35):e44030. doi: 10.1097/MD.0000000000044030.
2
Can proton pump inhibitors increase the risk of sudden unexpected death in Parkinson's disease (SUDPAR)?质子泵抑制剂会增加帕金森病患者意外猝死（SUDPAR）的风险吗？
Clinics (Sao Paulo). 2025 Jul 31;80:100721. doi: 10.1016/j.clinsp.2025.100721.
3
Gastroesophageal reflux disease and osteoporosis: A bidirectional Mendelian randomization study.胃食管反流病与骨质疏松症：一项双向孟德尔随机化研究。
Medicine (Baltimore). 2025 Apr 4;104(14):e42083. doi: 10.1097/MD.0000000000042083.
4
The aldose reductase inhibitors AT-001, AT-003 and AT-007 attenuate human keratinocyte senescence.醛糖还原酶抑制剂AT - 001、AT - 003和AT - 007可减轻人类角质形成细胞的衰老。
Front Aging. 2024 Dec 17;5:1466281. doi: 10.3389/fragi.2024.1466281. eCollection 2024.
5
Current study of pathogenetic mechanisms and therapeutics of chronic atrophic gastritis: a comprehensive review.慢性萎缩性胃炎发病机制与治疗的当前研究：一项综述
Front Cell Dev Biol. 2024 Dec 10;12:1513426. doi: 10.3389/fcell.2024.1513426. eCollection 2024.
6
Proton pump inhibitor use and risk of stroke: A systematic review and meta-analysis.质子泵抑制剂的使用与中风风险：一项系统评价和荟萃分析。
Pak J Med Sci. 2024 Nov;40(10):2432-2440. doi: 10.12669/pjms.40.10.10409.
7
Proton pump inhibitors and cardiovascular risk: a critical review.质子泵抑制剂与心血管风险：一项批判性综述。
Future Cardiol. 2024;20(14):779-794. doi: 10.1080/14796678.2024.2412910. Epub 2024 Oct 28.
8
Frataxin Loss Promotes Angiotensin II-Induced Endothelial-to-Mesenchymal Transition.铁蛋白轻链缺失促进血管紧张素 II 诱导的内皮细胞向间充质细胞转化。
J Am Heart Assoc. 2024 Aug 6;13(15):e034316. doi: 10.1161/JAHA.124.034316. Epub 2024 Jul 18.
9
Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database.奥美拉唑与高血压风险：现有文献及世界卫生组织全球药物警戒数据库分析
Drugs Real World Outcomes. 2024 Dec;11(4):735-744. doi: 10.1007/s40801-024-00441-2. Epub 2024 Jun 22.
10
Cardiotoxic Effects Produced by Omeprazole and Methylene Blue in an Animal Model of Cardiac Ischemia and Reperfusion and Potential Implications for the Pharmacological Strategy for Vasoplegic Syndrome.奥美拉唑和亚甲蓝在心脏缺血再灌注动物模型中产生的心脏毒性作用及其对血管麻痹综合征药理学策略的潜在影响
Biomedicines. 2024 Mar 6;12(3):582. doi: 10.3390/biomedicines12030582.
本文引用的文献
1
Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.质子泵抑制剂与痴呆风险的关联：基于药物流行病学索赔数据分析。
JAMA Neurol. 2016 Apr;73(4):410-6. doi: 10.1001/jamaneurol.2015.4791.
2
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.质子泵抑制剂的使用与慢性肾脏病风险
JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193.
3
Age intrinsic loss of telomere protection via TRF1 reduction in endothelial cells.通过内皮细胞中TRF1减少导致的端粒保护的年龄相关性内在丧失。
Biochim Biophys Acta. 2016 Feb;1863(2):360-7. doi: 10.1016/j.bbamcr.2015.11.034. Epub 2015 Dec 1.
4
Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold.慢性肾脏病中内皮细胞功能障碍的发病机制：一项回顾性研究及未来展望
Kidney Res Clin Pract. 2015 Jun;34(2):76-82. doi: 10.1016/j.krcp.2015.05.003. Epub 2015 Jun 4.
5
Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.阿尔茨海默病发病机制中的血管功能障碍——内皮细胞介导机制及随后的恶性循环综述。
Neurobiol Dis. 2015 Oct;82:593-606. doi: 10.1016/j.nbd.2015.08.014. Epub 2015 Aug 23.
6
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population.质子泵抑制剂的使用与普通人群心肌梗死风险
PLoS One. 2015 Jun 10;10(6):e0124653. doi: 10.1371/journal.pone.0124653. eCollection 2015.
7
Protein-protein interactions within the ensemble, eukaryotic V-ATPase, and its concerted interactions with cellular machineries.该整体内的蛋白质-蛋白质相互作用、真核生物V-ATP酶及其与细胞机制的协同相互作用。
Prog Biophys Mol Biol. 2015 Oct;119(1):84-93. doi: 10.1016/j.pbiomolbio.2015.05.003. Epub 2015 May 29.
8
Proton pump inhibitors and vascular function: A prospective cross-over pilot study.质子泵抑制剂与血管功能：一项前瞻性交叉试点研究。
Vasc Med. 2015 Aug;20(4):309-16. doi: 10.1177/1358863X14568444. Epub 2015 Apr 2.
9
Molecular mechanisms of autophagy in the cardiovascular system.心血管系统中自噬的分子机制。
Circ Res. 2015 Jan 30;116(3):456-67. doi: 10.1161/CIRCRESAHA.114.303788.
10
Transient delivery of modified mRNA encoding TERT rapidly extends telomeres in human cells.编码端粒酶逆转录酶（TERT）的修饰mRNA的瞬时递送可迅速延长人类细胞中的端粒。
FASEB J. 2015 May;29(5):1930-9. doi: 10.1096/fj.14-259531. Epub 2015 Jan 22.
Zotero 插件